References
- Yamamoto M, Yamanaka T, Baba H, et al. The postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinoma. J Surg Oncol 2008; 97: 231–5
- Korenaga D, Haraguchi M, Tsujitani S, et al. Clinicopathological features of mucosal carcinoma of the stomach with lymph node metastasis in eleven patients. Br J Sirig 1986; 73: 431–3
- Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg 1992; 79: 241–4
- Jang JS, Lee EJ, Lee SW, et al. Endoscopic submucosal dissection for early gastric cancer and gastric adenoma. Korean J Gastroenterol 2007; 49: 356–63
- Chang CC, Lee IL, Chen PJ, et al. Endoscopic submucosal dissection for gastric epithelial tumors: a multicenter study in Taiwan. J Formos Med Assoc 2009; 108: 38–44
- Andreas P, Daniela G, Hans A, et al. Endoscopic submucosal dissection of early cancers, flat adenomas, and submucosal tumors in the gastrointestinal tract. Clin Gastroenterol H 2009; 7: 149–55
- Benyan Wu, Daohong Wu, Mengwei Wang, et al. Recurrence in patients following curative resection of early gastric carcinoma. J Surg Oncol 2008; 98: 411–14
- Lim JS, Kim MJ, Yun MJ, et al. Comparison of CT and 18F-FDG Pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma. Korean J Radiol 2006; 7: 249–56
- Jadvar H, Tatlidil R, Garcia AA, Conti PS. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol 2003; 58: 215–21
- Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-) malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med 2001; 28: 1766–9
- Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl med 2003; 44: 1200–9
- Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343: 254–61
- Hossein J, Robert W, Peter S, et al. 2-Deoxy-2-[F-18]Fluoro-D-Glucose-Positron emission tomography/computed tomography imaging evaluation of esophageal cancer. Mol Imaging Biol 2006; 8: 193–200
- Chang YC, Nagasue N, Abe S, et al. Alpha fetoprotein producing early gastric cancer with liver metastasis: report of three cases. Gut 1991; 32: 542–5
- Hirasaki S, Tanimizu M, Tsuzuki T, et al. Seronegative alpha-fetoprotein-producing early gastric cancer treated with endoscopic mucosal resection and additional surgery. Intern Med 2004; 43: 926–30
- Otsuji E, Kuriu Y, Ichikawa D, et al. Prediction of lymph node metastasis by size of early gastric carcinoma. Hepatogastroenterology 2007; 54: 602–5
- Folli S, Dente M, Dell'Amore D, et al. Early gastric cancer: prognostic factors in 223 patients. Br J Surg 1995; 82: 952–6
- Yamao T, Shirao K, Ono H, et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer 1996; 77: 602–6
- Hanaoka N, Tanabe S, Higuchi K, et al. A rare case of histologically mixed-type intramucosal gastric cancer accompanied by nodal recurrence and liver metastasis after endoscopic submucosal dissection. Gastrointest Endosc 2009; 69: 588–90
- Cserni G, Bianchi S, Boecker W, et al. European Working Group for Breast Screening Pathology. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 2005; 103: 358–67
- Rampaul RS, Miremadi A, Pinder SE, et al. Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res 2001; 3: 113–16
- Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English edn. Gastric Cancer 1998;1:10–24.
- Hur J, Park MS, Lee JH, et al. Diagnostic accuracy of multidetector row computed tomography in t- and n staging of gastric cancer with histopathologic correlation. J Comput Assist Tomogr 2006; 30: 372–7
- Yamada A, Oguchi K, Fukushima M, Imai Y, Kadoya M. Evaluation of 2-deoxy-2- [18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. Ann Nucl Med 2006; 20: 597–604
- De PT, Flamen P, Van CE, et al. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging 2002; 29: 525–9
- Stahl A, Ott K, Weber WA, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 2003; 30: 288–95
- Shoda H, Kakugawa Y, Saito D, et al. Evaluation of 18F-2-Deoxy-2- Fluoro-Glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy. Br J Cancer 2007; 97: 1493–8
- Choi SR, Jang JS, Lee JH, et al. Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy. Dig Dis Sci 2006; 51: 2081–6